We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prévention du virus respiratoire syncitial (VRS) chez les nourrissons : une petite révolution ?
- Authors
Veluzat, Simon
- Abstract
RSV infections are a burden on children's health and on our healthcare system. Yet, our therapeutic and preventive arsenal against it has until now been very thin. Palivizumab has proved effective in protecting infants at risk, but its high cost and monthly injection requirement have prevented its widespread use. The arrival of new antibodies on the market gives us hope of a turning point in the prevention of these infections. The development of vaccines against RSV is an ideal complement to the limited range of treatments currently available. The coming winters will put our prevention strategies to the test, but the data from the current winter are already encouraging.
- Subjects
PALIVIZUMAB; RESPIRATORY syncytial virus infections; ANTIVIRAL agents; RESPIRATORY syncytial virus; IMMUNOGLOBULINS
- Publication
Médecine Thérapeutique: Pédiatrie, 2023, Vol 25, Issue 3/4, p172
- ISSN
1286-5494
- Publication type
Article
- DOI
10.1684/mtp.2023.0783